PRQR Stock Analysis: Buy, Sell, or Hold?
PRQR - ProQR Therapeutics N.V. Ordinary Shares
$1.56
0.12 (8.33%)
▲
5d:
+1.96%
30d:
-5.45%
90d:
-11.36%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When PRQR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PRQR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PRQR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PRQR is currently trading at $1.56, which is considered fair relative to its 30-day fair value range of $1.45 to $1.60.
Technical Outlook: Technically, PRQR is showing sideways momentum. Immediate support is located at $1.35, while resistance sits at $1.63. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: PRQR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+468.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRQR is showing sideways momentum. Immediate support is located at $1.35, while resistance sits at $1.63. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: PRQR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+468.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.45 -
$1.60
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
- BULLISH: Trading 468.9% below Wall St target ($8.88)
Trading Range Analysis
30-Day Trading Range
$1.45 -
$1.60
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.63
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.30
Wall Street Target
$8.88
(+468.9%)
Revenue Growth (YoY)
-57.1%
Share & Embed Analysis
Last updated: June 16, 2026 2:41 AM ET
Data refreshes hourly during market hours. Next update: 3:41 AM
Data refreshes hourly during market hours. Next update: 3:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRQR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 64 BUY |
